Science ❯Biotechnology

Antibody Development

Venom Immunity Hyperimmunization

Intranasal Molecular Shield Antibody Blocks Pollen Allergy and Asthma in Mice

Humanization of the XA19 antibody is underway with clinical trials targeted to begin in two to three years.

Experimental Antivenom Derived from Tim Friede's Blood Shows Promise in Preclinical Tests